Study identifies drug combinations that protect stem cell heart grafts from rejection

While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise immunosuppressive regimen needed remains…

Continue Reading

News Source: medicalxpress.com